Search Media Items

Uterine sarcoma treatment is primarily surgery, with or without radiation or chemotherapy. Learn more about the treatments for newly diagnosed uterine or recurrent sarcoma in this expert-reviewed summary.

Testicular cancer treatment options depend upon tumor characteristics and include surgery, radiation, chemotherapy, and observation. Learn more about the treatment of newly diagnosed and recurrent testicular cancer in this expert-reviewed summary.

Levels of Evidence for Integrative, Alternative, and Complementary Therapies is about how to weigh the strength of the evidence obtained in cited research studies. Get detailed information this formal ranking system in this summary for clinicians.

Coenzyme Q10 is a dietary supplement, and use of it as a treatment for cancer in humans has been investigated in only a limited manner. Get detailed information about Coenzyme Q10 use in cancer in this summary for clinicians.

Newcastle disease virus (NDV)- based therapy has been reported to be of benefit in clinical studies, but results are considered inconclusive. Study designs were weak and the study reports were generally incomplete. Get detailed information about NDV use in cancer in this summary for clinicians.

Laetrile (Amygdalin) has shown little anticancer activity in animal studies and no anticancer activity in human clinical trials. Laetrile is not approved for use in the United States. Get detailed information about use of Laetrile for cancer in this summary for clinicians.

Hydrazine sulfate has shown no anticancer activity in randomized clinical trials. Data on its effectiveness in cancer-related cachexia are inconclusive. Get detailed information about hydrazine sulfate as a treatment for people with cancer in this summary for clinicians.

Cartilage (bovine and shark) has been studied as a treatment for people with cancer and other conditions for more than 30 years. Few human studies of cartilage in cancer have been reported to date, and the results are inconclusive. Get detailed information in this clinician summary.

Cancell, Cantron, and Protocel have been promoted by its manufacturers as an effective therapy for cancer and other diseases. No animal or human study has been published in a peer-reviewed scientific journal to show safety or effectiveness in treating cancer. Learn more in this clinician summary.

714-X is not approved for use in the United States. No study of 714-X has been published in a peer-reviewed scientific journal to show it is safe or effective in treating cancer.